research A Case Report of Verruca Vulgaris on Basis of Alopecia Areata Successfully Treated with Diphenylcyclopropenone
Diphenylcyclopropenone (DPCP) effectively treated both alopecia areata and verruca vulgaris.
Search
forLearn
0 / 0 results — no results
Research
5 / 597 resultsresearch Cutaneous Manifestations of Dabrafenib: A Selective Inhibitor of Mutant BRAF in Patients with Metastatic Melanoma
Dabrafenib can cause skin growths and sometimes low-grade skin cancer.
research Change of the Diagnostic Distribution in Applicants to Dermatology After COVID-19 Pandemic: What It Whispers to Us?
The COVID-19 pandemic led to fewer dermatology visits and changed the types of skin conditions patients experienced.
research Comparison of Patients’ Diagnoses in a Dermatology Outpatient Clinic During the COVID-19 Pandemic Period and Pre-Pandemic Period
The pandemic changed how often certain skin conditions were diagnosed.
research Mucocutaneous Manifestations in Children with Human Immunodeficiency Virus Infection
Children with HIV often have skin problems that can indicate the severity of their immune system damage.
Community Join
1 / 1 resultscommunity The expected timeline for PP405 - Next update at AAD Annual Meeting in March 2026 ?
A new hair loss treatment, PP405, showed promising Phase 2a results with 31% of patients experiencing over 20% hair density increase without systemic absorption, avoiding hormonal side effects. The treatment is expected to be expensive, with Phase 3 trials starting mid-2026, and there is skepticism about the data's strength.